Saudi Banks Q2 14 preliminary results Net income growth accelerated on operating income strength NIMs surprised positively, provisions were mixed 15th July 2014 Coverage Universe Al Rajhi Recommendation Target Price (LC) HOLD 71.40 ANB Recommendation Target Price (LC) HOLD 28.45 BSF Recommendation Target Price (LC) HOLD 32.70 Riyad Recommendation Target Price (LC) HOLD 17.30 SABB Recommendation Target Price (LC) BUY 56.50 Samba Recommendation Target Price (LC) BUY 47.60 SHB Recommendation Target Price (LC) BUY 48.00 Q2 14 NET INCOME BEATS CONSENSUS BY 5% ON AGGREGATE Saudi banks reported preliminary Q2 14 results over the past two weeks. For the seven banks we cover, net income was 5% above consensus on aggregate. Net income growth accelerated to 7% YoY (vs 4% YoY in Q1 14) on the back of strong loan book expansion, NIM resilience and double-digit non-interest income growth across the board (see below for details). SHB, one of our top picks among Saudi banks, posted the highest net income growth at 28% YoY, followed by Riyad, BSF and SABB posting YoY growth at mid-teens. Samba and ANB lagged them with single digit YoY growth, while Al Rajhi’s net income dropped YoY for the fourth consecutive quarter. NIM RESILIENCE SURPRISED POSITIVELY We expected NIM pressures to persist this quarter on the back of low asset yields and limited room for improvement in cost of funding. Q2 14 results surprised us positively as the banks’ NIMs (on average assets) were flat to +12bps QoQ. We note that YoY trends were mixed (ranging from -11bps to +10bps YoY), yet still better than expected based on our discussions with major banks’ CFOs in May. However, outperforming names were not surprising: 1) SABB, which had more stable NIMs vs peers over the last two years, led the pack with 12bps QoQ improvement in Q2 14; 2) Samba, which preferred NIM resilience over NII growth over the last two years, also delivered 10bps QoQ NIM improvement. PROVISIONS WERE MIXED; SHB, SABB AND SAMBA SAW DECLINES YOY In our June update, we highlighted that cost of risk would not ease off this year as we expected SAMA to retain its conservative stance in terms of coverage, particularly on collective provisioning. ANB, Riyad and BSF, which held the lowest collective provision coverage (as % of performing loans) at the end of 2013, reported c.30-45% YoY rise in estimated provisions which were based on our individual C/I ratio assumptions. We believe they utilized their operating income strength (10-15% YoY rise) to ramp up their collective provision coverage. On the other hand, SABB, Samba and SHB, our three BUY recommended stocks, saw provisions decline YoY thanks to better underlying asset quality, in our view. TOP PICKS SHB AND SABB DELIVERED SOLID RESULTS SHB and SABB, our top picks among the seven banks we cover in Saudi Arabia, delivered 11% and 17% YoY operating income growth, respectively (vs 10% for the seven banks on aggregate). Moreover, thanks to declines in estimated provisions YoY, their net income growth in Q2 14 was among the top end of the peer range. Both stocks look attractive on valuation as they are trading in line with Saudi peer average of 1.7x 15E P/B despite their superior returns (consensus 15E ROE of 17.8% and 17.0% for SHB and SABB respectively vs Saudi peer average of 14.4%). Saudi banks are trading on 1.9x one year forward P/B (market cap. weighted average for the seven banks we cover), versus their 5 year average of 2.0x and the highs of 2.5x in late 2010. Q2 14 Results Sector Coverage Suha Urgan +9714 3199 769 [email protected] Taher Safieddine, CFA +9714 3199 785 [email protected] Loans (QoQ) Net interest income (YoY) Non-interest income (YoY) Provisions* (YoY) Net income (YoY) Net income vs Consensus** Al Rajhi 4% 5% 10% 45% -8% -1% ANB 5% 8% 13% 30% 9% 7% BSF 2% 17% 12% 46% 16% 9% Riyad 3% 8% 29% 36% 17% 6% SABB 3% 7% 16% -51% 15% 8% Samba 6% 1% 12% -63% 7% 9% SHB 6% 17% 17% -29% 28% 12% Aggregate 4% 7% 16% 19% 7% 5% Source: SHUAA Capital * SHUAA estimates based on bank specific C/I ratio assumptions ** Bloomberg consensus
© Copyright 2024 ExpyDoc